IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.989
NA - Nord America 2.597
AS - Asia 1.902
SA - Sud America 614
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.517
RU - Federazione Russa 1.010
SG - Singapore 861
BR - Brasile 525
IE - Irlanda 490
IT - Italia 484
CN - Cina 462
SE - Svezia 287
HK - Hong Kong 280
DE - Germania 192
PL - Polonia 139
FI - Finlandia 136
VN - Vietnam 101
IN - India 79
FR - Francia 64
GB - Regno Unito 63
CA - Canada 39
AR - Argentina 36
MX - Messico 30
AT - Austria 24
NL - Olanda 23
BE - Belgio 19
EC - Ecuador 19
ID - Indonesia 19
TR - Turchia 19
BD - Bangladesh 17
JP - Giappone 14
UA - Ucraina 14
ZA - Sudafrica 11
CI - Costa d'Avorio 10
ES - Italia 9
MA - Marocco 9
VE - Venezuela 8
IQ - Iraq 7
LT - Lituania 7
TN - Tunisia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
AZ - Azerbaigian 5
KE - Kenya 5
PE - Perù 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
RO - Romania 4
BO - Bolivia 3
EU - Europa 3
HN - Honduras 3
NP - Nepal 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BH - Bahrain 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 8.154
Salva come PNG Salva come JPEG
Città #
Moscow 545
Dublin 487
Ashburn 457
Singapore 415
Dallas 376
Chandler 320
Hong Kong 276
Nyköping 217
Messina 189
Beijing 188
Warsaw 137
Munich 133
Los Angeles 73
Princeton 73
The Dalles 71
Helsinki 70
Medford 64
Ann Arbor 50
Des Moines 47
Buffalo 37
Jacksonville 37
São Paulo 37
New York 35
Turku 30
Pune 29
Wilmington 29
Ho Chi Minh City 27
Tianjin 25
Bremen 24
Dearborn 24
Redondo Beach 22
Hyderabad 20
Seattle 20
Cambridge 19
Lappeenranta 19
Belo Horizonte 18
Nuremberg 18
Palermo 17
Rio de Janeiro 17
Jinan 16
Boardman 15
Brussels 15
London 15
Brooklyn 14
Chicago 14
Hanoi 14
Redwood City 14
Chennai 13
Rome 13
Tokyo 13
Boston 12
Curitiba 12
Duncan 12
Falls Church 12
San Francisco 12
Santa Clara 12
Houston 11
Mexico City 11
Milan 11
Montreal 11
Vienna 11
Abidjan 10
Amsterdam 10
Brasília 10
Catania 10
Jakarta 10
Orem 10
Zhengzhou 10
Denver 9
Poplar 9
Porto Alegre 9
Campinas 8
Changsha 8
Dong Ket 8
Guayaquil 8
Ningbo 8
Shenyang 8
Frankfurt am Main 7
Haikou 7
Livorno 7
Manaus 7
Nanjing 7
Phoenix 7
San Mateo 7
Shanghai 7
Taizhou 7
Toronto 7
Ankara 6
Atlanta 6
Council Bluffs 6
Johannesburg 6
New Delhi 6
San Jose 6
Woodbridge 6
Baghdad 5
Bagheria 5
Baku 5
Collegeville 5
Fortaleza 5
Goiânia 5
Totale 5.262
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 319
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 256
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 197
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 187
A Nouvel serum MicroRNA signature to screen ATTR 181
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 167
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 165
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 158
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 158
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 133
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 131
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 130
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 129
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 128
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 127
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 124
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 119
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 118
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 113
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 113
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 113
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 106
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 104
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 100
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 99
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 98
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 97
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 96
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 95
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 94
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 94
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 93
Considerable post-partum worsening in a patient with CMT2E 92
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 92
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 91
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 91
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 90
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 87
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 85
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 85
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 84
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 84
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 83
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 82
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 80
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 80
The THAOS: record of patients from our site. 79
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 78
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 77
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 75
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 75
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 75
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 75
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 74
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 72
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 71
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 71
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 71
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 70
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 70
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 70
Impact of environmental factors and physical activity on disability and quality of life in CIDP 69
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 69
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 67
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 66
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 65
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 65
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 64
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 60
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 60
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 60
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 59
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 59
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 57
TTR-FAP: a single-center experience in Sicily, an Italian endemic area 57
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 55
null 54
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 53
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 53
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 53
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 53
Rare among rare: Phenotypes of uncommon CMT genotypes 52
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 51
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 49
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 49
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 46
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 46
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 46
null 30
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 29
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 28
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 26
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 22
null 22
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 22
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 20
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 18
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 17
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 16
The neurophysiological lesson from the Italian CIDP database 16
Totale 8.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 27 42 18 23 74 21 16
2021/2022474 14 48 3 16 40 11 48 28 16 22 31 197
2022/20231.280 106 115 78 76 86 114 19 61 570 13 27 15
2023/2024395 27 56 21 27 32 108 16 32 5 25 6 40
2024/20252.220 72 22 48 142 138 141 202 318 444 124 213 356
2025/20263.177 322 466 438 358 481 1.112 0 0 0 0 0 0
Totale 8.484